The involvement of subcellular Ago2 in diabetic cardiomyopathy is dual-faceted and can be summarised as follows: First, Ago2 suppresses ATP synthesis by inhibiting the production of mitochondrial ATP synthase subunits. The gene discussed is AGO2; the disease is diabetic cardiomyopathy.